Trump's Bold Move: Executive Order to Seize Health Research Funding Control Sparks Outcry
Context mode is active. Hover over any highlighted term to see its definition. Click a nested term to go deeper.
Washington is buzzing today, September 20, 2026, after reports surfaced detailing former President Donald Trump directive to his budget chief to draft an executive order aimed at placing vast federal health research funding directly under the control of political appointees. This proposed move, which would create a new board to decide National Institutes of Health (NIH) grants with unanimous political approval, has ignited a firestorm, with critics warning of severe consequences for scientific independence and public health. The bombshell plan follows previous criticisms of federal research funding cuts and seeks to centralize decision-making, bypassing traditional scientific review processes. Administration officials argue these changes are necessary to ensure funding for 'solid science research,' but opponents fear it would inject partisan politics into crucial medical and public health investigations, mirroring concerns about the politicization of science seen during the Trump administration's handling of the COVID-19 pandemic. Such a consolidation of power could stifle innovation, erode public trust in vital medical findings, and ultimately weaken the nation's ability to tackle future health crises. The revelation is expected to fuel intense debate, especially as health policy becomes a significant battleground in the lead-up to the 2026 midterm elections and the anticipated 2028 presidential race, where Trump remains a key figure. Lawmakers from both parties have already voiced criticism, suggesting potential legislative safeguards might be sought to protect research funding from undue political interference. All eyes are now on the political fallout and how this development will reshape discussions around scientific integrity and executive authority.